Last news
Meizu's Mr. Gu Binbin at MWC25: Meizu is Back to Global Market with Flyme AI Ecosystem

Meizu's Mr. Gu Binbin at MWC25: Meizu is Back to Global Market with Flyme AI Ecosystem

BARCELONA, Spain, March 5, 2025 /PRNewswire/ -- Meizu has marked its back to global market at MWC in Barcelona. In exclusive interactions with several media outlets, Mr. Gu Binbin, the executive director of overseas business, discussed the brand's...

Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials

Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials

From many clicks to one query, drug supply managers can more quickly access, analyze, and visualize the trial supply data they need. PHILADELPHIA, March 6, 2025 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes...

Branch Unveils New Capabilities To Maximize Campaign ROI in a Privacy-First Era

Branch Unveils New Capabilities To Maximize Campaign ROI in a Privacy-First Era

The Only Mobile Measurement Partner (MMP) To Offer Advanced Data Protection Meeting HIPPA Requirements MOUNTAIN VIEW, Calif., March 5, 2025 /PRNewswire/ -- Branch, the industry's leading linking and measurement partner for growth-focused teams,...

A new report by McKinsey & Company and the World Federation of the Sporting Goods Industry explores the state of the industry and growth themes for 2025 and beyond

A new report by McKinsey & Company and the World Federation of the Sporting Goods Industry explores the state of the industry and growth themes for 2025 and beyond

HOW SPORTING GOODS BRANDS CAN TURN UNCERTAINTY INTO OPPORTUNITY BERN, Switzerland, March 5, 2025 /PRNewswire/ -- McKinsey & Company and the World Federation of the Sporting Goods Industry (WFSGI) are pleased to announce the publication of...

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative cancer therapy based on membrane lipid therapy, announced today optimistic results from its ongoing clinical trial evaluating LAM561...

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive members of its Board of...

Beyond Music Acquires Copyright Stake in BTS Hit Song "Butter"

Beyond Music Acquires Copyright Stake in BTS Hit Song "Butter"

SEOUL, South Korea, March 5, 2025 /PRNewswire/ -- Beyond Music, Asia's leading music intellectual properties (IPs) investment and data management company, has acquired a copyright stake in "Butter," the global hit song by BTS. This deal was...

2025 Call for Code Engages Developers to Build AI Solutions that Address Social and Humanitarian Issues

2025 Call for Code Engages Developers to Build AI Solutions that Address Social and Humanitarian Issues

In its eighth year, Call for Code presents a series of SDG-focused hackathons throughout the year, kicking off with a competition to build AI agents BOULDER, Colo., March 5, 2025 /PRNewswire/ -- Today, Call for Code Creator David Clark Cause,...

menu
menu